Human papillomavirus vaccine market revenue is projected to exceed $10.8 billion by 2031

0

Human Papillomavirus Vaccine Market Growth

The report includes the analysis of regional as well as HPV market trends, key players, market segments, and market growth strategies.

Portland, Oregon, United States, October 27, 2022 / Eintresswire.com/ โ€“ Allied Market Research Published A Report, Titleded, โ€œ๐‡๐ฎ๐ฆ๐š๐ง ๐๐š๐ฉ๐ข๐ฅ๐ฅ๐จ๐ฆ๐š๐ฏ๐ข๐ซ๐ฎ๐ฌ (๐‡๐๐•) ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฒ ๐“๐ฒ๐ฉ๐ž (๐“๐ž๐ญ๐ซ๐š๐ฏ๐š๐ฅ๐ž๐ง๐ญ, ๐๐ข๐ฏ๐š๐ฅ๐ž๐ง๐ญ, ๐๐ข๐ฏ๐š๐ฅ๐ž๐ง๐ญ), ๐›๐ฒ ๐๐ฒ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž (๐‚๐ž๐ซ๐ฏ๐ข๐œ๐š๐ฅ ๐‚๐š๐ง๐œ๐ž๐ซ, ๐‚๐š๐ง๐œ๐ž๐ซ ๐•๐ฎ๐ฅ๐ฏ๐š๐ซ, ๐•๐ฎ๐ฅ๐ฏ๐š๐ซ ๐‚๐š๐ง๐œ๐ž๐ซ ๐‚๐š๐ง๐œ๐ž๐ซ, ๐‚๐š๐ง๐œ๐ž๐ซ, ๐Ž๐ซ๐จ๐ฉ๐ก๐š๐ซ๐ฒ๐ง๐ ๐ž๐š๐ฅ ๐Ž๐ญ๐ก๐ž๐ซ๐ฌ, ๐Ž๐ญ๐ก๐ž๐ซ๐ฌ), ๐›๐ฒ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐•๐ž๐ซ๐ญ๐ข๐œ๐š๐ฅ (๐๐ฎ๐›๐ฅ๐ข๐œ ๐๐ซ๐ข๐ฏ๐š๐ญ๐ž ๐€๐ฅ๐ฅ๐ข๐š๐ง๐œ๐ž๐ฌ ๐€๐ฅ๐ฅ๐ข๐š๐ง๐œ๐ž๐ฌ ๐†๐จ๐ฏ๐ž๐ซ๐ง๐ฆ๐ž๐ง๐ญ, ๐Ž๐ญ๐ก๐ž๐ซ๐ฌ, ๐Ž๐ญ๐ก๐ž๐ซ๐ฌ): ๐†๐ฅ๐จ๐›๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ง๐ ๐…๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ, 2021-2030. โ€

There are more than 100 types of HPV, of which more than 40 are sexually transmitted and can affect the genitals, mouth, or throat. HPV is a common infection, according to the Centers for Disease Control and Prevention (CDC), itโ€™s ubiquitous, and although people have few sexual partners, many people who have sex will experience some changes at any time. Some urogenital HPV infections may not cause health problems. However, some types of HPV can cause disease and even cancer of the uterus, cervix, and throat.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ (245 ๐๐š๐ ๐ž๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐‚๐ก๐š๐ซ๐ญ๐ฌ, ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ, ๐…๐ข๐ ๐ฎ๐ซ๐ž๐ฌ): https://www.alliedmarkesearch.com/request-lampe/14697

The human papillomavirus vaccine is used to treat people with the virus, which is transmitted from person to person through skin-to-skin contact. Cervarix and Gardasil, two human papillomavirus vaccines, are most commonly used in women between the ages of 9 and 30. Human papillomavirus (HPV) is also a sexually transmitted disease. The HPV virus is distinct from HIV and HSV, commonly referred to as herpes. The HPV vaccine protects the body from infection with many types of human papillomavirus.

The increase in HPV-related diseases leads to an increase in demand for HPV vaccines, which are expected to be a major driver of the global human papillomavirus vaccine market during the forecast period. There are only three types of vaccines on the market: bivalent, quadrivalent and nonavalent. These three vaccines were very successful in preventing types 16 and 18 infections, which account for 70% of cervical cancer cases.

๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ -19? ๐€๐ฌ๐ค ๐ญ๐จ ๐Ž๐ฎ๐ซ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ:

๐Š๐ž๐ฒ ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐ฉ๐ซ๐จ๐Ÿ๐ข๐ฅ๐ž๐ :

โžค Merck & Co.
โžค GlaxoSmithKline plc.
โžคSanofi
โžคJohnson & Johnson
โžค AstraZeneca
โžค Serum Institute of India Pvt. GmbH
โžค Bharat Biotech.
โžค Xenetic Biosciences
โžค Inovio Pharmaceuticals
โžค Novartis AG

๐๐ฒ ๐“๐ฒ๐ฉ๐ž

tetravalent
nonavalent
Bivalent

๐๐ฒ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ˆ๐ง๐๐ข๐œ๐š๐ญ๐ข๐จ๐ง

cervical cancer
anal cancer
Vulva and Vaginal Cancer
penile cancer
oropharyngeal cancer
Other

๐๐ฒ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐•๐ž๐ซ๐ญ๐ข๐œ๐š๐ฅ

Public and private alliances
government agencies
doctors
Other

๐…๐‘๐„๐๐”๐„๐๐“๐‹๐˜ ๐€๐’๐Š๐„๐ƒ ๐๐”๐„๐’๐“๐ˆ๐Ž๐๐’?
Q1 What are the driving factors and opportunities in the Global Human Papillomavirus Vaccines Market?
Q2. What current trends will impact the Human Papillomavirus Vaccines market in the next few years?
Q3 Which regions offer more business opportunities for Global Human Papillomavirus Vaccine in the future?
Q4 What are the key growth strategies being pursued by the global Human Papillomavirus Vaccines Market players?
Q5. Who are the key market players in Human Papillomavirus Vaccine market space?

https://www.alliedmarketresearch.com/purchase-enquiry/14697

David Korrea
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Share.

Comments are closed.